Welcome to Anziva Pharmaceuticals!
We are committed to developing innovative treatments that prioritize effectiveness, stability and safety, ensuring fewer side effects for patients. Discover our cutting-edge products and learn how we strive to improve performance and elevate patient care. Join us in shaping a healthier future.
Anziva Pharmaceuticals LLC, led by founder Dr. Simerdeep Singh Gupta, is dedicated to improving product performance through pharmaceutical innovation.
We specialize in improving existing drugs using the 505(b)(2) pathway, allowing for faster and cost-effective approvals by leveraging existing safety and efficacy data.
Our team is dedicated to developing several New Therapeutic Entities (NTEs) in our pipeline, with a focus on enhancing existing market products.